#oncology

- Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacific”) and MSD have embarked ...

U.S. Vice President Joe Biden said  the "moonshot" initiative he leads aimed at finding cures for cancer was "the ...

Research investigators in Singapore have developed a new high throughput method that identifies how ribonucleic acid ...

On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of ...

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

- Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd ...

-Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the ...

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

- The Lien Foundation calls on governments and policy makers to hasten and improve their provision of palliative ...

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...

based companion diagnostic (CDx) in immuno-oncologyDARMSTADT, Germany & NEW YORK--(Antara/BUSINESS WIRE.

- Pathway Genomics, a global precision medical diagnostics company, announced the launch of ...